Trials / Completed
CompletedNCT00441415
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Compared to Clindamycin 0.1% / Benzoyl Peroxide 5% Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 272 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the non-inferior efficacy of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel when compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in Subjects with acne vulgaris after a 12-week treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene BPO |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2007-02-28
- Last updated
- 2021-02-17
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00441415. Inclusion in this directory is not an endorsement.